TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A 2026 article in The Lancet Healthy Longevity argues that sarcopenia and age-related mobility loss should be understood as problems involving the whole motor system, including the brain, nerves and muscles. The authors propose changes to research and assessment, but say new tests have not yet been shown to outperform existing screening or improve outcomes.
Researchers writing in The Lancet Healthy Longevity argue that age-related weakness and mobility loss should be understood as problems of the whole motor system, not just declining muscle. Their proposed reframing could influence how clinicians assess older adults and how researchers design treatments, but the authors say new assessment measures still need testing against existing approaches.
The article, by Lucas B. R. Orssatto and colleagues, says the standard explanation for sarcopenia—age-related loss of muscle, strength and physical function—does not fully account for why older adults become weaker. The authors point to evidence that muscle loss explains only a modest share of strength decline, and that people with similar amounts of muscle can have very different strength and mobility.
They describe the motor system as the chain involved in producing movement, from the brain and spinal cord through nerves and their connections to muscle. With aging, the authors say, movement planning may slow, nerve signals may become less reliable or weaker, and balance and awareness of body position can decline. In this account, muscle may remain present while less effective motor commands reach it.
The authors also highlight the difference between muscle size and everyday function, a topic explored in research on exercise and muscle aging. Rising from a chair depends on speed and power, not simply bulk; the article says power declines earlier and faster with age than muscle mass. Exercise can improve strength and mobility even when measurable muscle mass does not change, while efforts that increase muscle do not necessarily produce comparable gains in what people can do.
A Broader Target for Mobility Care
The proposed shift matters because weakness and falls can threaten independence, and treatment focused mainly on muscle may miss other contributors to a person’s difficulty moving. A broader account could prompt clinicians to look beyond muscle quantity and consider how well the nervous system coordinates and drives movement.
The public-health stakes are substantial in Australia, according to figures cited in the Medical Xpress report: there were 253,800 fall-related hospitalizations in 2024–25. In the preceding year, 6,722 Australians died following a fall, and fall injuries were estimated to cost the health system $5.4 billion. Those figures describe the scale of falls, but do not establish that the proposed motor-system approach would reduce them.
The authors say a broader model could redirect research toward interventions that improve strength, movement and everyday function, rather than concentrating predominantly on increasing muscle mass. That is a research rationale, not proof that any particular new treatment or clinical test works better.
Products Worth Considering
BowFlex Results Series SelectTech Adjustable Dumbbells, Pair
Bowflex SelectTech 840 Adjustable Kettlebell
Levoit Vital 100S-P Air Purifier for Home and Pets
As an affiliate, we earn on qualifying purchases.
How Sarcopenia Assessment Is Changing
The report says sarcopenia diagnosis has already moved beyond relying on muscle mass alone. Grip strength, gait speed and chair-stand performance are used because they predict outcomes such as falls, disability and death better than muscle mass does, according to the authors. They argue that clinical definitions have changed faster than the explanation of what causes the condition.
Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm for screening, assessing and managing poor muscle health in primary care. The Lancet Healthy Longevity article builds on that discussion by asking whether current approaches adequately account for the nervous system and other parts of movement control.
The authors suggest clinicians may also pay attention to how quickly a patient rises from a chair, unsteadiness during sustained effort, hand dexterity and changes in walking while talking. They recommend closer examination when weakness is asymmetric, rapid or out of proportion to muscle loss. These are proposals for clinical attention, not validated replacements for existing screening.
“We propose that sarcopenia is better understood as a disease of the aging motor system.”
— Lucas B. R. Orssatto and colleagues, authors of the article in The Lancet Healthy Longevity
Tests and Benefits Still Unproven
The article proposes a different model of sarcopenia, but it does not establish that motor-system measures improve diagnosis, treatment or patient outcomes. The authors explicitly say that the suggested measures have not been shown to outperform current screens on outcomes or cost. It is also unclear which practical tests could reliably capture changes in nerve function in a typical primary-care setting.
Access to neuromuscular expertise is uneven in primary care, the authors acknowledge. The report does not provide evidence that a medication review, a particular exercise plan or any proposed test alone prevents falls. It also does not give results from a clinical trial comparing a motor-system-focused approach with existing care.
Validation Before Practice Changes
The authors call for international working groups responsible for diagnostic criteria to consider a five-point research agenda. They also call for investment in studies that validate practical tests clinicians can use, guidelines that support a staged assessment approach, and trials measuring nerve as well as muscle.
For now, the proposed model is a research and clinical framework rather than a demonstrated change in standard care. The next evidence needed is whether broader assessments identify causes of weakness more accurately and whether interventions guided by them improve mobility, independence or fall-related outcomes. The article does not specify a timeline for those studies or for any changes to diagnostic guidelines.
Key Questions
What is sarcopenia?
Sarcopenia is age-related loss of muscle, strength and physical function. The researchers argue that its causes and effects should not be explained by muscle changes alone.
What does the motor-system model include?
It includes the brain, spinal cord, nerves and their connections to muscle, as well as muscle itself. The authors say changes across this system may affect movement, strength, balance and coordination.
Are the proposed tests ready to replace current screening?
No. The authors say the suggested measures have not been shown to outperform existing screens on outcomes or cost. They call for validation before the approach is adopted more widely.
Why does the article discuss falls?
Falls are a serious consequence of reduced strength and mobility. The Medical Xpress report cites 253,800 fall-related hospitalizations in Australia in 2024–25, while noting that the proposed framework has not been shown to reduce falls.
Source: medicalxpress.com
